Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism

Arch Endocrinol Metab. 2018 Feb;62(1):106-124. doi: 10.20945/2359-3997000000015.

Abstract

Objective To present an update on the diagnosis and treatment of hypoparathyroidism based on the most recent scientific evidence. Materials and methods The Department of Bone and Mineral Metabolism of the Sociedade Brasileira de Endocrinologia e Metabologia (SBEM; Brazilian Society of Endocrinology and Metabolism) was invited to prepare a document following the rules set by the Guidelines Program of the Associação Médica Brasileira (AMB; Brazilian Medical Association). Relevant papers were retrieved from the databases MEDLINE/PubMed, LILACS, and SciELO, and the evidence derived from each article was classified into recommendation levels according to scientific strength and study type. Conclusion An update on the recent scientific literature addressing hypoparathyroidism is presented to serve as a basis for the diagnosis and treatment of this condition in Brazil.

Publication types

  • Practice Guideline

MeSH terms

  • Brazil
  • Evidence-Based Medicine*
  • Humans
  • Hypoparathyroidism / diagnosis*
  • Hypoparathyroidism / drug therapy*
  • Hypoparathyroidism / etiology
  • Societies, Medical